<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Human isotype-dependent inhibitory antibody responses against Mycobacterium tuberculosis</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2016-10-11">11 October 2016</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Natalie</forename><surname>Zimmermann</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Max Planck Institute for Infection Biology</orgName>
								<orgName type="laboratory">Research Group Molecular Immunology</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Immunology</orgName>
								<orgName type="department" key="dep2">Max Planck Institute for Infection Biology</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">B Cell Immunology</orgName>
								<orgName type="institution">German Cancer Research Center</orgName>
								<address>
									<settlement>Heidelberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Verena</forename><surname>Thormann</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Max Planck Institute for Infection Biology</orgName>
								<orgName type="laboratory">Research Group Molecular Immunology</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Bo</forename><surname>Hu</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Max Planck Institute for Infection Biology</orgName>
								<orgName type="laboratory">Research Group Molecular Immunology</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Anne-Britta</forename><surname>Köhler</surname></persName>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Immunology</orgName>
								<orgName type="department" key="dep2">Max Planck Institute for Infection Biology</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Aki</forename><surname>Imai-Matsushima</surname></persName>
							<affiliation key="aff3">
								<orgName type="department" key="dep1">Department of Molecular Biology</orgName>
								<orgName type="department" key="dep2">Max Planck Institute for Infection Biology</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Camille</forename><surname>Locht</surname></persName>
							<affiliation key="aff4">
								<orgName type="laboratory">UMR 8204 -CIIL -Centre for Infection and Immunity of Lille</orgName>
								<orgName type="institution">University of Lille</orgName>
								<address>
									<postCode>U1019</postCode>
									<settlement>Lille</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="laboratory">UMR 8204</orgName>
								<orgName type="institution">CNRS</orgName>
								<address>
									<settlement>Lille</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
							<affiliation key="aff6">
								<orgName type="department">Inserm</orgName>
								<address>
									<postCode>U1019</postCode>
									<settlement>Lille</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
							<affiliation key="aff7">
								<orgName type="institution">CHU Lille</orgName>
								<address>
									<settlement>Lille</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
							<affiliation key="aff8">
								<orgName type="institution">Institut Pasteur de Lille</orgName>
								<address>
									<settlement>Lille</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Eusondia</forename><surname>Arnett</surname></persName>
							<affiliation key="aff9">
								<orgName type="department" key="dep1">Center for Microbial Interface Biology</orgName>
								<orgName type="department" key="dep2">Department of Microbial Infection and Immunity</orgName>
								<orgName type="institution">The Ohio State University</orgName>
								<address>
									<settlement>Columbus</settlement>
									<region>OH</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Larry</forename><forename type="middle">S</forename><surname>Schlesinger</surname></persName>
							<affiliation key="aff9">
								<orgName type="department" key="dep1">Center for Microbial Interface Biology</orgName>
								<orgName type="department" key="dep2">Department of Microbial Infection and Immunity</orgName>
								<orgName type="institution">The Ohio State University</orgName>
								<address>
									<settlement>Columbus</settlement>
									<region>OH</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Thomas</forename><surname>Zoller</surname></persName>
							<affiliation key="aff10">
								<orgName type="department">Department of Infectious Diseases and Respiratory Medicine</orgName>
								<orgName type="institution">Charité University Medical Center</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Mariana</forename><surname>Schürmann</surname></persName>
							<affiliation key="aff10">
								<orgName type="department">Department of Infectious Diseases and Respiratory Medicine</orgName>
								<orgName type="institution">Charité University Medical Center</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Stefan</forename><forename type="middle">He</forename><surname>Kaufmann</surname></persName>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Immunology</orgName>
								<orgName type="department" key="dep2">Max Planck Institute for Infection Biology</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Hedda</forename><surname>Wardemann</surname></persName>
							<email>h.wardemann@dkfz.de</email>
							<affiliation key="aff0">
								<orgName type="department">Max Planck Institute for Infection Biology</orgName>
								<orgName type="laboratory">Research Group Molecular Immunology</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">B Cell Immunology</orgName>
								<orgName type="institution">German Cancer Research Center</orgName>
								<address>
									<settlement>Heidelberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Human isotype-dependent inhibitory antibody responses against Mycobacterium tuberculosis</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2016-10-11">11 October 2016</date>
						</imprint>
					</monogr>
					<idno type="MD5">3F3CF58E329889A7BFF567EF2F635D7A</idno>
					<idno type="DOI">10.15252/emmm.201606330</idno>
					<note type="submission">Received 23 February 2016 | Revised 30 August 2016 | Accepted 6 September 2016 |</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:21+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>antibodies</term>
					<term>B cells</term>
					<term>infection</term>
					<term>isotype</term>
					<term>Mycobacterium tuberculosis Subject Categories Immunology</term>
					<term>Microbiology, Virology &amp; Host Pathogen Interaction</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Accumulating evidence from experimental animal models suggests that antibodies play a protective role against tuberculosis (TB).</s><s>However, little is known about the antibodies generated upon Mycobacterium tuberculosis (MTB) exposure in humans.</s></p><p><s>Here, we performed a molecular and functional characterization of the human B-cell response to MTB by generating recombinant monoclonal antibodies from single isolated B cells of untreated adult patients with acute pulmonary TB and from MTB-exposed healthcare workers.</s><s>The data suggest that the acute plasmablast response to MTB originates from reactivated memory B cells and indicates a mucosal origin.</s><s>Through functional analyses, we identified MTB inhibitory antibodies against mycobacterial antigens including virulence factors that play important roles in host cell infection.</s><s>The inhibitory activity of anti-MTB antibodies was directly linked to their isotype.</s><s>Monoclonal as well as purified serum IgA antibodies showed MTB blocking activity independently of Fc alpha receptor expression, whereas IgG antibodies promoted the host cell infection.</s><s>Together, the data provide molecular insights into the human antibody response to MTB and may thereby facilitate the design of protective vaccination strategies.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>Tuberculosis (TB) is a major cause of death worldwide.</s><s>Despite the extensive research, no effective vaccine against adult pulmonary TB has been developed <ref type="bibr" target="#b2">(Andersen &amp; Kaufmann, 2014)</ref>.</s><s>Therefore, longterm antibiotic treatment remains the standard of care <ref type="bibr">(Zumla et al, 2013)</ref>.</s></p><p><s>Stable Mycobacterium tuberculosis (MTB) infection is established in the lung after bacterial uptake by macrophages, which generally fail to eliminate the bacteria and instead serve as major MTB reservoir <ref type="bibr" target="#b20">(Guirado et al, 2013)</ref>.</s><s>However, mycobacteria can also directly infect and replicate within epithelial cells, which has been associated with mycobacterial dissemination from the lung <ref type="bibr" target="#b33">(Pethe et al, 2001;</ref><ref type="bibr" target="#b13">Castro-Garza et al, 2002)</ref>.</s><s>Surface-exposed MTB antigens play a major role in host cell invasion as shown, for example, for heparin-binding hemagglutinin (HBHA), an adhesion molecule that interacts with proteoglycans on the surface of epithelial cells, thereby facilitating MTB entry <ref type="bibr" target="#b33">(Pethe et al, 2001;</ref><ref type="bibr" target="#b25">Locht et al, 2006;</ref><ref type="bibr" target="#b32">Menozzi et al, 2006)</ref>.</s><s>Moreover, lipids and lipoglycans, such as the abundant lipoarabinomannan (LAM), are major components of the MTB cell wall and promote the bacterial uptake through the interaction with mannose receptors expressed on the host cell surface <ref type="bibr" target="#b40">(Schlesinger et al, 1994;</ref><ref type="bibr" target="#b22">Kang et al, 2005;</ref><ref type="bibr" target="#b49">Torrelles et al, 2008)</ref>.</s></p><p><s>It is long known that T cells play a major role in TB immunity and are the target of current vaccination strategies <ref type="bibr" target="#b15">(Cooper, 2009;</ref><ref type="bibr" target="#b2">Andersen &amp; Kaufmann, 2014)</ref>.</s><s>However, more recent evidence points toward a role of B cells in modulating immune responses to MTB infection, for example, as antigen-presenting cells or through the production of cytokines and antibodies <ref type="bibr">(Glatman-Freedman &amp; Casadevall, 1998;</ref><ref type="bibr" target="#b46">Teitelbaum et al, 1998;</ref><ref type="bibr" target="#b7">Bosio et al, 2000;</ref><ref type="bibr" target="#b14">Chambers et al, 2004;</ref><ref type="bibr" target="#b37">Roy et al, 2005;</ref><ref type="bibr" target="#b28">Maglione et al, 2007</ref><ref type="bibr" target="#b29">Maglione et al, , 2008;;</ref><ref type="bibr" target="#b1">Achkar et al, 2015)</ref>.</s><s>Antibodies can exert their functions in two ways: by the direct blocking of host cell invasion and neutralization of bacterial products, or indirectly through Fc-mediated complement and cell activation mechanisms through Fc receptors <ref type="bibr" target="#b35">(Ravetch &amp; Clynes, 1998)</ref>.</s><s>Steady-state mucosal immune responses are characterized by the production of IgA, whereas inflammatory conditionsincluding acute pulmonary TB-are associated with class switching to IgG <ref type="bibr" target="#b9">(Brandtzaeg et al, 1997;</ref><ref type="bibr" target="#b16">Demkow et al, 2007)</ref>.</s></p><p><s>Recent studies revealed that monoclonal antibodies against various mycobacterial surface antigens including LAM and HBHA can mediate protection in mouse models <ref type="bibr" target="#b46">(Teitelbaum et al, 1998;</ref><ref type="bibr" target="#b33">Pethe et al, 2001;</ref><ref type="bibr" target="#b14">Chambers et al, 2004;</ref><ref type="bibr" target="#b21">Hamasur et al, 2004;</ref><ref type="bibr" target="#b26">Lopez et al, 2009)</ref>.</s><s>However, whether MTB-neutralizing antibodies against these structures also develop upon natural exposure in humans and induce the formation of B-cell memory remains to be determined.</s><s>To address these questions, we analyzed the antibody repertoire of plasmablasts, a population of antibody-secreting B cells that circulate transiently in the blood upon acute infection and reflect the ongoing humoral immune response to pathogens, and the memory B-cell response to HBHA <ref type="bibr" target="#b53">(Wrammert et al, 2008;</ref><ref type="bibr" target="#b24">Li et al, 2012)</ref>.</s><s>We demonstrate that MTB-exposed healthcare workers (HCW) and patients with active pulmonary TB generate B-cell antibody responses against mycobacterial surface antigens including LAM and HBHA, which mediate protection against the host cell invasion.</s><s>Surprisingly, our data demonstrate that the inhibitory activity of anti-MTB antibodies depends directly on their isotype.</s><s>IgA, but not IgG, antibodies specific for different MTB surface antigens can block MTB uptake by lung epithelial cells independently of the expression of IgA Fc receptors.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Human anti-MTB plasmablast and memory B-cell antibody response</head><p><s>To characterize the antibody response to MTB, we initially screened peripheral blood samples from a cohort of 17 untreated and 8 drugtreated patients with active pulmonary TB for the presence of circulating plasmablasts and for serum antibody reactivity to MTB antigens (Fig <ref type="figure" target="#fig_0">1</ref>).</s><s>Healthy donors (HD) without contact with TB patients served as controls.</s><s>About 50% of patients mounted specific IgG and IgA serum responses against MTB with higher antibody levels against cell membrane antigens compared with secreted culture filtrate proteins <ref type="bibr">(Fig 1A and B)</ref>.</s><s>Circulating CD19 + CD27 + + CD38 + plasmablasts were present in about 38% of all patients <ref type="bibr">(Fig 1C)</ref>.</s><s>The cells expressed low levels of CD19 and were positive for the surface markers CD86, CD84, and CD24 indicative of their recent activation status <ref type="bibr">(Fig 1D)</ref>.</s><s>The frequency of plasmablasts was highest during early acute TB and waned upon drug treatment, whereas serum IgG levels increased over six months of antibiotic combination therapy <ref type="bibr">(Fig 1E)</ref>.</s><s>Several untreated patients with prominent serum antibody responses lacked the detectable plasmablast levels in the circulation, suggesting that these donors had been infected for prolonged times so that their circulating plasmablast response had waned <ref type="bibr">(Fig 1F)</ref>.</s></p><p><s>Next, we selected three patients with circulating plasmablasts and strong anti-MTB serum Ig responses for the molecular characterization of their plasmablast antibodies (TB7, TB24, TB33; Fig <ref type="figure" target="#fig_4">2A;</ref> Appendix Table <ref type="table">S1</ref>).</s><s>From these donors, the IGH and corresponding IGK or IGL light chain transcripts of over 230 single isolated plasmablasts were amplified and sequenced (GenBank accession number KX947385-KX949063).</s><s>To exclude any influence of the antibiotic drug treatment on our analyses, all samples were taken before the onset of therapy (Appendix Table <ref type="table">S1</ref>).</s><s>Consistently, the majority of TB plasmablasts in all donors expressed somatically mutated antibodies encoded by diverse Ig genes (Fig 2B <ref type="figure">;</ref> Appendix Table <ref type="table">S2</ref>).</s><s>MTB expresses a large number of diverse antigens.</s><s>We therefore expected a high degree of polyclonality in the plasmablast response.</s><s>Indeed, only a few cells from individual donors expressed Ig genes with identical heavy and light chain rearrangements as well as shared somatic mutations and thus were clonally related (GenBank accession number KX947385-KX949063).</s><s>The relative bias toward IgA and near-complete absence of IgM expression compared with circulating memory B cells from the same donors indicated a mucosal origin <ref type="bibr">(Fig 2C)</ref>.</s></p><p><s>Plasmablasts can develop from naı ¨ve B cells or mutated memory B cells.</s><s>The relatively high frequency of somatic mutations in plasmablasts at the levels comparable to circulating memory B cells under steady-state conditions suggested that the plasmablast response developed from reactivated memory B cells rather than from nonmutated naı ¨ve B cells that had been newly activated during active disease onset <ref type="bibr">(Fig 2B;</ref><ref type="bibr" target="#b47">Tiller et al, 2007)</ref>.</s><s>To determine whether circulating anti-MTB memory B cells were detectable in the absence of active disease, we screened a cohort of healthy MTB-exposed HCW for the presence of circulating  Nearly all antibodies were somatically mutated at the levels comparable to the published data from unselected memory B cells of HD and we identified clusters of clonally expanded cells in all four donors <ref type="bibr">(Fig 2H and I;</ref><ref type="bibr" target="#b50">Tsuiji et al, 2006;</ref><ref type="bibr" target="#b47">Tiller et al, 2007;</ref><ref type="bibr" target="#b5">Berkowska et al, 2015)</ref>.</s><s>IGH gene isotype analyses revealed a clear dominance of IgA and IgM over IgG anti-HBHA memory B-cell antibodies.</s><s>The low frequency of IgG was more pronounced in HCW than in TB patients, whereas IgA was particularly more abundant in HCW, suggesting an association of disease onset with the induction of IgG responses <ref type="bibr">(Fig 2J)</ref>.</s><s>In summary, the data provide evidence that circulating plasmablasts in the peripheral blood of patients with active pulmonary TB develop from a polyclonal set of mutated and reactivated memory B cells.</s><s>The high frequency of IgA anti-HBHA memory B cells in HCW suggests that memory is formed upon primary MTB exposure presumably from mucosal immune responses.</s><s>Active TB could lead to the reactivation of preexisting memory B cells and the</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Plasmablast antibodies frequently target MTB surface antigens</head><p><s>Antibodies targeting surface-exposed bacterial antigens likely play a functional role in the anti-MTB response.</s><s>To determine whether the B-cell response to MTB produces functional antibodies, we cloned the IGH and corresponding IGK or IGL genes from 113 IgA + and IgG + plasmablasts and produced the recombinant monoclonal antibodies in vitro (Appendix Table <ref type="table">S2</ref>).</s><s>All antibodies were initially produced as IgG1 to allow for the direct comparison of their antigen-binding capacity independently of the original plasmablast isotype.</s><s>We then tested the antibodies for binding to MTB cell lysate or whole bacteria by ELISA <ref type="bibr">(Fig 3A and B)</ref>.</s><s>On average, 40% of all recombinant monoclonal antibodies were MTB reactive in these assays <ref type="bibr">(Fig 3C)</ref>.</s><s>To identify nonspecific binding of antibodies, we also tested all antibodies for binding to irrelevant and structurally diverse antigens (dsDNA, insulin, LPS).</s><s>Cross-reactivity was detected for about 16% of antibodies, indicating that the majority of plasmablast antibodies were antigen specific (Appendix Table <ref type="table">S2</ref>).</s></p><p><s>A large fraction of anti-MTB antibodies recognized whole MTB bacteria in the ELISA, suggesting that they may target bacterial surface antigens <ref type="bibr">(Fig 3B)</ref>.</s><s>We therefore tested a selected set of MTBreactive and nonreactive antibodies for binding to cell membrane antigens by <ref type="bibr">ELISA (Fig 3D)</ref>.</s><s>Indeed, the majority (57.6%, 15/26) of anti-MTB but only 1 of 15 nonreactive control antibodies was reactive with purified cell membrane antigens (Appendix Table <ref type="table">S2</ref>).</s><s>For individual antibodies, binding to the mycobacterial surface was confirmed by flow cytometry, suggesting that they recognized epitopes that are accessible to antibodies in vivo (Fig <ref type="figure">3E</ref> and Appendix Table <ref type="table">S2</ref>).</s><s>Thus, the human plasmablast antibody response to MTB infection predominantly targets mycobacterial surface antigens.</s></p><p><s>LAM is a major component of the mycobacterial cell surface and a target of protective antibodies <ref type="bibr" target="#b10">(Brown et al, 2003;</ref><ref type="bibr" target="#b21">Hamasur et al, 2004)</ref>.</s><s>We therefore interrogated whether LAM served as target antigen of human anti-MTB plasmablast antibodies (Fig <ref type="figure">4A-C</ref>; Appendix Table <ref type="table">S2</ref>).</s><s>By Western blot, FACS, and ELISA, we identified two antibodies that recognize MTB ManLAM.</s><s>Antibody TB24PB037 lacked reactivity with PILAM from the nonpathogenic Mycobacterium smegmatis, demonstrating its high specificity for MTB compared with the CS-35-positive control antibody <ref type="bibr">(Fig 4D)</ref>.</s></p><p><s>HBHA represents another surface antigen and MTB virulence factor, which is targeted by antibodies <ref type="bibr" target="#b31">(Menozzi et al, 1996;</ref><ref type="bibr" target="#b33">Pethe et al, 2001;</ref><ref type="bibr" target="#b23">Kohama et al, 2008)</ref>.</s><s>Although none of the plasmablast antibodies recognized HBHA (data not shown), the detection of HBHA-reactive memory B cells in HCW and TB patients with acute disease <ref type="bibr">(Fig 2D and F)</ref> prompted us to determine whether these cells expressed HBHA-specific antibodies (Fig 4E <ref type="figure">-G</ref>).</s><s>Upon Ig gene cloning and in vitro expression of antibodies from HBHA-reactive memory B cells, we identified 25 HBHA binders by ELISA or Western blot.</s><s>Thirteen antibodies of all isotypes lacked crossreactivity and were therefore HBHA specific (Appendix Table <ref type="table">S3</ref>).</s><s>Binding of HBHA-reactive antibodies to the outer surface of mycobacteria was confirmed by fluorescence microscopy <ref type="bibr">(Fig 4G)</ref>.</s></p><p><s>Thus, we conclude that MTB-exposed individuals mount highaffinity plasmablast and memory antibody responses against MTB surface antigens such as ManLAM and HBHA relevant for host cell infection.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Antibody isotype-dependent functional differences in MTB inhibition</head><p><s>To determine the potential role of both plasmablast and memory B-cell antibodies in MTB infection, we tested a selected set of 41 MTB-reactive recombinant monoclonal antibodies in an in vitro infection assay with A549 human lung epithelial cells (Fig <ref type="figure">5</ref> and Appendix Table <ref type="table">S4</ref>).</s><s>A549 cells are type II alveolar epithelial cells that have been shown to play a role in early MTB infection <ref type="bibr" target="#b6">(Bermudez &amp; Goodman, 1996;</ref><ref type="bibr" target="#b13">Castro-Garza et al, 2002;</ref><ref type="bibr" target="#b39">Sato et al, 2002;</ref><ref type="bibr" target="#b38">Ryndak et al, 2015;</ref><ref type="bibr" target="#b54">Zimmermann et al, 2016)</ref>.</s><s>We initially expressed and tested a set of antibodies that had been cloned from IgA-positive plasmablasts including the anti-LAM antibody TB24PB037 (Fig <ref type="figure">5A and B</ref>).</s><s>To mimic the original plasmablast and memory B-cell isotype and subclass, we expressed the antibodies as ◀ Figure <ref type="figure" target="#fig_4">2</ref>. Somatic hypermutation level and isotype distribution of single-cell-sorted plasmablasts and antigen-specific memory B cells.</s></p><p><s>A Gating strategy, phenotype, and frequency of circulating plasmablasts (CD19 + CD27 ++ CD38 + ) isolated by flow cytometric cell sorting from three TB patients (TB7, TB24, and TB33) in comparison with one representative HD.</s><s>Boxes indicate sort gates.</s><s>The plasmablast frequency is indicated.</s><s>B Absolute number of somatic hypermutations (SHM) in the IGHV, IGKV, and IGLV segments of IgA and IgG plasmablast antibody genes sequenced from TB7, TB24, and TB33.</s><s>The absolute number of sequences analyzed is indicated below the graph.</s><s>Geometric means with SEM are indicated in gray.</s><s>SHM means of historic data from sorted CD27 + IgA + or CD27 + IgG + cells from the peripheral blood of HD are indicated in red for comparison <ref type="bibr" target="#b47">(Tiller et al, 2007;</ref><ref type="bibr" target="#b5">Berkowska et al, 2015)</ref>.</s><s>C Isotype distribution of plasmablast and memory B cells from TB7, TB24, and TB33.</s><s>PB, plasmablasts (CD19 + CD27 ++ CD38 + ); M, memory B cells (CD19 + CD27 + ).</s><s>D Gating strategy, phenotype, and frequency of HBHA-reactive memory B cells (CD19 + CD27 + HBHA + ) in the peripheral blood of one representative TB patient (TB29), healthcare worker (HCW) 2, and HD, respectively.</s><s>IgA1 or IgA2, respectively (Appendix Table <ref type="table">S2</ref>; <ref type="bibr" target="#b27">Lorin &amp; Mouquet, 2015)</ref>.</s><s>For TB24PB037 and six additional plasmablast antibodies of unknown antigen specificity, preincubation of the mycobacteria reduced the intracellular bacterial load by 20-50% compared with the medium control, whereas 5/12 IgA plasmablast antibodies and the non-MTB-reactive isotype control showed no effect (Fig 5A <ref type="figure">and B</ref>).</s><s>Inhibition was not associated with a specific IgA subclass, suggesting that the differences in the functional properties of individual plasmablast antibodies can be explained by the differences in the target antigen/epitope specificity or affinity.</s><s>Antibodies without effect may target antigens or epitopes irrelevant for infection.</s></p><p><s>To determine whether IgG plasmablast antibodies showed similar inhibitory activities for MTB, we tested 26 MTB-reactive IgG antibodies that had been cloned from IgG + plasmablasts in the same assay (Fig <ref type="figure">5A and B</ref>).</s><s>Surprisingly, none of the IgG antibodies was able to inhibit infection.</s><s>Instead, most monoclonal anti-MTB IgG plasmablast antibodies increased the mycobacterial load (Fig <ref type="figure">5B</ref>).</s><s>The results were confirmed with anti-HBHA memory B-cell IgA and IgG antibodies (Fig <ref type="figure">5C and D</ref>).</s><s>Whereas IgA anti-HBHA monoclonal antibodies impaired the infection, HBHA-reactive IgG antibodies promoted the infection or had no effect.</s></p><p><s>The observation that IgA antibodies inhibited the infection of epithelial cells whereas IgG antibodies promoted mycobacterial invasion suggested that the differences in isotype rather than antigen or epitope specificity were associated with functional differences in MTB inhibitory activity.</s><s>We therefore cloned and directly compared IgG and IgA versions of 10 MTB-reactive antibodies including the anti-LAM antibodies <ref type="bibr">(Fig 5E)</ref>.</s><s>Indeed, for all tested antibodies, IgG increased, while IgA decreased the bacterial load.</s><s>Antigen binding was not influenced by antibody isotype as measured by ELISA and the effect was concentration dependent (Appendix Fig S1 <ref type="figure">)</ref>.</s><s>To determine whether the differential expression of Fc receptors may be underlying the isotype-dependent differences in antibodymediated inhibition, we used flow cytometry and PCR to measure the IgG and IgA Fc receptor expression levels of A549 and primary human airway epithelial cells (Fig <ref type="figure" target="#fig_8">6A and B</ref>).</s><s>Compared with THP-1 macrophages as a positive control, A549 and primary human airway epithelial cells did not express the IgA Fc receptor CD89 or conventional IgG Fc receptors, which promote the bacterial uptake through IgG immune complexes (  <ref type="figure" target="#fig_8">6C</ref>) was not IgA Fc receptor mediated and uptake of IgG-coated bacteria was not influenced by FccR but more likely by FcRn expression.</s></p><p><s>To determine whether isotype-associated differences in mycobacterial uptake were also observed for serum antibodies, we purified serum IgA and IgG from TB patients and non-TB-exposed HDs (Fig <ref type="figure" target="#fig_9">7</ref>).</s><s>Increased uptake of MTB by A549 cells was detected for purified polyclonal IgG preparations from the serum of individual TB patients, whereas purified serum IgA reduced the mycobacterial load similar to the monoclonal plasmablast antibodies <ref type="bibr">(Fig 7A and B)</ref>.</s><s>In summary, our data suggest that isotype plays a critical role in determining the inhibitory vs. noninhibitory properties at the monoclonal and polyclonal serum antibody level in TB.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>The role of humoral immune responses in TB is still highly controversial <ref type="bibr" target="#b1">(Achkar et al, 2015)</ref>.</s><s>We here demonstrate that the plasmablast antibody response to MTB infection in humans generates functionally active antibodies.</s><s>The expression of high-binding somatically mutated and class-switched antibodies suggests that these antibodies underwent multiple rounds of selection to reach higher affinity and most likely developed with the help of T cells in germinal center reactions.</s><s>In low-incidence countries, the vast majority of active TB cases are believed to be the consequence of disease reactivation in individuals with latent TB infection, who failed to contain MTB within solid granulomas <ref type="bibr" target="#b41">(Small et al, 1994)</ref>.</s><s>Thus, it is likely that the plasmablast response studied here originated from reactivated memory B cells that were generated during local immune responses to primary MTB infection.</s><s>Indeed, proliferating and nonproliferating IgA + plasma cells as well as small numbers of IgG plasma cells could be detected adjacent to caseous necrotic granulomas in the lung sections of TB patients with active disease (Fig <ref type="figure" target="#fig_0">EV1</ref>).</s><s>The clear bias toward IgA and the fact that MTB-specific IgA and IgG memory B cells can be isolated from the peripheral blood of healthy TB-exposed HCW-as demonstrated for anti-HBHA memory B cells-suggests that the anti-MTB B-cell response spreads from the lung to the periphery independently of active TB disease.</s></p><p><s>Our data demonstrate that a substantial fraction of the plasmablast response is directed against cell membrane antigens including ManLAM, a target of protective antibodies <ref type="bibr" target="#b10">(Brown et al, 2003)</ref>.</s><s>Thus, the targeted induction of high-affinity antibodies and memory B cells against MTB surface antigens such as ManLAM or HBHA could protect against primary infection prior to MTB entry into the lung parenchyma and the establishment of stable infection, for example, by inhibiting the interaction with the mannose receptor on macrophages or through binding to proteoglycans on the surface of epithelial cells, respectively <ref type="bibr" target="#b46">(Teitelbaum et al, 1998;</ref><ref type="bibr" target="#b33">Pethe et al, 2001;</ref><ref type="bibr" target="#b21">Hamasur et al, 2004;</ref><ref type="bibr" target="#b22">Kang et al, 2005)</ref>.</s><s>Although we did not detect differences in the specificity of antibodies cloned from different donors, it is likely that the target antigen specificity and the affinity of memory B cell, plasmablast, and total serum antibodies play a major role in determining the overall functionality of the humoral immune response.</s><s>However, antibody cross-reactivity does not seem to influence the inhibitory activity of anti-MTB antibodies.</s></p><p><s>Airway responses are typically IgA biased, and passive immunization with IgA can protect against early MTB infection of the lung <ref type="bibr" target="#b9">(Brandtzaeg et al, 1997;</ref><ref type="bibr" target="#b36">Rojas &amp; Apodaca, 2002;</ref><ref type="bibr" target="#b52">Williams et al, 2004;</ref><ref type="bibr" target="#b11">Buccheri et al, 2007;</ref><ref type="bibr" target="#b4">Balu et al, 2011)</ref>.</s><s>However, IgG responses develop particularly under inflammatory conditions and anti-MTB IgG serum levels are higher in patients with active disease compared with HCW <ref type="bibr" target="#b16">(Demkow et al, 2007;</ref><ref type="bibr" target="#b34">Pukazhvanthen et al, 2014)</ref>.</s><s>Differences in antigen specificity and/or affinity or low anti-MTB antibody titers may explain the lack of any inhibitory or enhancing effect for individual monoclonal antibodies and serum IgA or IgG preparations from individual donors, respectively.</s><s>How antibody isotype differences influence the course of natural MTB infection in humans and whether isotype switching precedes the development of active TB or reflects a consequence of disease remain to be determined, but our data suggest that the expression of IgG may promote MTB uptake by alveolar epithelial cells.</s></p><p><s>Experiments in mice have demonstrated a protective role for antibodies in certain infection models.</s><s>For example, intranasal administration of MTB together with a mouse monoclonal anti-HBHA IgG delayed bacterial dissemination to the spleen and liver, without affecting the bacterial load in the lung <ref type="bibr" target="#b33">(Pethe et al, 2001)</ref>.</s><s>In contrast, intravenous infection and administration of a LAM-specific murine IgG led to a reduction in the bacterial load in the lung and was associated with the prolonged survival <ref type="bibr" target="#b21">(Hamasur et al, 2004)</ref>.</s><s>Collectively, these published data suggest that the protective function of anti-MTB antibodies, at least in part, may depend on the target antigen and host cell type, the local environment, and the route of administration (mucosa vs. periphery; <ref type="bibr" target="#b18">Falero-Diaz et al, 2000;</ref><ref type="bibr" target="#b33">Pethe et al, 2001;</ref><ref type="bibr" target="#b14">Chambers et al, 2004;</ref><ref type="bibr" target="#b21">Hamasur et al, 2004;</ref><ref type="bibr" target="#b52">Williams et al, 2004;</ref><ref type="bibr" target="#b37">Roy et al, 2005;</ref><ref type="bibr" target="#b26">Lopez et al, 2009)</ref>.</s><s>However, no systematic comparison of isotypeassociated functional differences has been made previously.</s><s>Our data that antibody isotype differences in preexisting memory B cells and plasma cells together with the differences in the antigen/ epitope specificity of the antibody response may play a major role in modulating the course of the infection and the development and progression of disease in humans.</s><s>The targeted induction of IgA memory B cells and serum antibodies may help to protect from MTB infection or promote immunity upon primary exposure.</s><s>Due to the incomplete Fc receptor homology and the differences in expression patterns between mice and humans, mouse models may be insufficient to assess the isotype-associated functional differences for human antibodies in vivo even if chimeric antibody constructs with murine Fc parts were generated <ref type="bibr" target="#b8">(Bournazos et al, 2015)</ref>.</s><s>The development of mice expressing human Fc receptors may be necessary to overcome these limitations <ref type="bibr">(van Egmond et al, 1999;</ref><ref type="bibr" target="#b3">Bakema &amp; van Egmond, 2011;</ref><ref type="bibr" target="#b42">Smith et al, 2012)</ref>.</s><s>Thus, a better understanding of the mechanisms underlying the development, induction, and function of IgA vs. IgG responses in humans as well as the identification of protective MTB target epitopes can form the basis for the rational design of a vaccine, which not only prevents TB disease, but also stable MTB infection.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study participants</head><p><s>Patients included in this study were 19-57 years of age (mean 42 AE 10 years).</s><s>Active pulmonary TB was diagnosed by the presence of typical clinical symptoms in conjunction with a chest X-ray compatible with TB as well as the diagnosis of MTB by sputum smear microscopy and/or positive culture.</s><s>After signed informed consent was obtained, peripheral blood was drawn before or after the start of therapy, as indicated.</s></p><p><s>Healthcare workers (HCW) who have been working with TB patients for several years were recruited at the Charite ´Hospital, Berlin.</s></p><p><s>Peripheral blood from healthy donors (HD) with no history of MTB infection and no reported contact with TB patients served as controls.</s><s>Peripheral blood mononuclear cells and plasma were purified using Ficoll gradient density centrifugation.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Bacteria, bacterial fractions, antigens, and cell lines</head><p><s>All assays were performed using the MTB strain H37Rv.</s><s>For the assessment of monoclonal antibody binding to mycobacteria by flow cytometry, the attenuated vaccine strain M. bovis Bacillus Calmette-Gue ´rin (BCG; Denmark background SSI) was used.</s><s>Bacteria were grown in Middlebrook 7H9 broth supplemented with Middlebrook ADC, 0.05% Tween-80, and 0.5% glycerol, or on Middlebrook 7H11 agar plates supplemented with Middlebrook OADC and 0.05% Tween-80.</s><s>Before the host cell infection, bacteria were diluted to a multiplicity of infection (MOI) of 1 and passaged five times through a tuberculin syringe to obtain the single-cell suspensions.</s><s>Unless indicated otherwise, all mycobacterial fractions including the H37Rv cell membrane fraction (NR-14831), H37Rv culture filtrate proteins (NR-14825), and all purified mycobacterial antigens including the H37Rv LAM (NR-14848) were obtained from BEI Resources, NIAID, NIH.</s></p><p><s>Native HBHA was expressed and purified from M. bovis BCG by heparin-Sepharose chromatography followed by reverse-phase HPLC as previously described <ref type="bibr" target="#b31">(Menozzi et al, 1996;</ref><ref type="bibr" target="#b30">Masungi et al, 2002)</ref>.</s></p><p><s>The human epithelial cell line A549 (ATCC; CCL-185) was cultured in DMEM (GIBCO) containing 10% heat-inactivated FBS, 10 mM HEPES buffer solution, 1 mM sodium pyruvate, and 2 mM L-glutamine.</s><s>The human monocytic THP-1 cell line (ATCC; TIB-202) was grown in RPMI 1640 (GIBCO), supplemented with 10% (v/v) heat-inactivated fetal calf serum (FCS; GIBCO), 1% (v/v) penicillinstreptomycin (GIBCO), 1% (v/v) sodium pyruvate (GIBCO), 1% (v/v) L-glutamine (GIBCO), and 1% (v/v) HEPES buffer (GIBCO).</s><s>The THP-1 monocytic cell line was differentiated into macrophages in RPMI medium containing 5 ng/ml phorbol 12-myristate 13-acetate (PMA, Sigma) for 72 h.</s><s>Primary human airway epithelial cells isolated from bronchial biopsies (hAECB) were purchased from Epithelix Sa `rl and propagated using gamma-irradiated NIH/3T3 cells as feeders <ref type="bibr" target="#b44">(Suprynowicz et al, 2012)</ref>.</s><s>hAECB cells at 70-80% confluence were separated from feeders by differential trypsinization and passaged to new culture vessels with CnT-Prime Airway medium (CELLnTEC) (A.</s><s>Imai-Matsushima and T.F.</s><s>Meyer, manuscript in preparation).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Flow cytometry</head><p><s>Purified peripheral blood mononuclear cells were stained for 30 min at 4°C with the following panel of mouse anti-human antibodies: CD19 PE-Cy7 (1:25 dilution), IgG V450 (1:20), CD27 FITC (1:25), CD38 PE (1:25), IgA biotin (1:100, all from BD Biosciences) and CD21 APC (1:20; eBioscience).</s><s>7AAD (1:200; Life Technologies) was used to exclude dead cells.</s><s>Biotin-labeled antibodies were detected with streptavidin-Qdot605 (1:100; Life Technologies).</s><s>BD Bioscience LSRII and Aria I instruments were used for flow cytometric analyses, and Aria II was used for single-cell sorting.</s></p><p><s>Human lung A549 epithelial cells, human nAECB primary epithelial cells, and human THP-1 monocytes were harvested from culture dishes using either trypsin-EDTA or 3% EDTA and stained with the following anti-human antibodies: CD89 PE (1:10; Biolegend), CD32 PE (1:10; Biolegend), CD16 PE (1:10; BD Biosciences), and CD64 PE (1:10; BD Biosciences).</s><s>PE-labeled mouse anti-human IgG1 j and IgG2 j antibodies (Biolegend) served as isotype controls.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Single-cell sorting, antibody cloning, and expression</head><p><s>Recombinant monoclonal antibodies were generated as previously described <ref type="bibr" target="#b48">(Tiller et al, 2008)</ref>.</s><s>In brief, total mRNA was transcribed using random hexamer primers.</s><s>IGH and IGK or IGL chain transcripts were amplified, sequenced, and cloned into heavy (IgG1, IgA1, or IgA2; <ref type="bibr" target="#b27">Lorin &amp; Mouquet, 2015)</ref> or light chain (Igj or Igk) expression vectors.</s><s>Recombinant antibodies were produced in human HEK 293T cells.</s><s>Recombinant monoclonal IgG or IgA antibodies were purified from culture supernatants using Protein G Fast Flow Sepharose (GE Healthcare) and Protein M Agarose (Invivogen), respectively.</s><s>Antibodies were eluted from the column by 0.1 M glycine pH 3 and the pH was neutralized with Tris buffer (pH 8).</s><s>IgG and IgA concentrations were determined by ELISA.</s><s>Individual batches of final antibody preparations were checked for endotoxin levels with the LAL Chromogenic Endotoxin Quantification Kit (Pierce) following the manufacturer's instructions before use in functional assays and were tested negative for LPS contaminations.</s></p><p><s>For the functional assays, purified serum antibodies were isolated from plasma using Protein G Fast Flow Sepharose (GE Healthcare) or Protein M Agarose (Invivogen), respectively.</s><s>Elution and concentration measurements were done as described for monoclonal antibody preparations.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Sequence analysis</head><p><s>Sequence analyses of the IGH, IGK, and IGL chain transcripts were performed using the IgBlast database to identify germline V(D)J genes with the highest homology.</s><s>Somatic hypermutations were determined as previously described <ref type="bibr" target="#b48">(Tiller et al, 2008)</ref>.</s><s>The isotype of memory B cells was determined by FACS analysis and the isotype of plasmablast cells by sequence analysis.</s><s>Sequence and FACS data matched to over 95% when directly compared for memory B cells of TB patient 7.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ELISA</head><p><s>Polyclonal serum or recombinant monoclonal antibody reactivity was measured as follows.</s><s>High-binding microtiter plates (Nunc) were coated with 50 ll H37Rv lysate, cell membrane fraction, culture filtrate proteins, or purified native HBHA at a final concentration of 10 lg/ml overnight at 4°C.</s><s>The plates were blocked with 4% BSA for 1.5 h at room temperature (RT), washed with 0.05% PBS-Tween or PBS, and incubated with diluted plasma or monoclonal antibodies (mAbs) in 0.05% PBS-Tween-1% BSA (plasma) for 2 h or PBS (mAbs) at RT followed by another washing step.</s><s>HRP-coupled goat anti-human IgG (H+L) antibody at a 1:1000 dilution (Jackson ImmunoResearch) and one-step ATBS substrate (Roche) were used for detection.</s><s>Area under the curve (AUC) values were calculated with the GraphPad PRISM software.</s><s>Antibodies were considered MTB reactive when they recognized antigens in the MTB lysate.</s><s>Antibodies were considered cross-reactive when they recognized at least two out of the four structurally different antigens: MTB lysate, double-stranded DNA, insulin, and LPS.</s><s>An internal negative control antibody (mGO53; <ref type="bibr" target="#b51">Wardemann et al, 2003)</ref> was included in all ELISAs.</s></p><p><s>Concentration ELISAs were performed as previously described <ref type="bibr" target="#b48">(Tiller et al, 2008)</ref>.</s><s>In brief, anti-human Fc-binding IgG (Dianova) was coated overnight at a 1:500 dilution at RT.</s><s>The plates were blocked with PBS-0.05%</s><s>Tween for 1 h at RT before incubation with the purified recombinant antibodies for 1.5 h at RT. Human IgG1k from the plasma of myeloma patients (Sigma) was used as standard.</s><s>Signals were detected as described above.</s></p><p><s>For LAM ELISAs, MTB Erdman ManLAM and M. smegmatis PILAM were purified and quality control was performed as described previously <ref type="bibr" target="#b49">(Torrelles et al, 2008)</ref>.</s><s>Purified LAM (1 lg/ well in 0.05 M carbonate-bicarbonate buffer, pH 9.5) was adhered to the wells of an ELISA medium binding plate overnight at 37°C; control wells were left without LAM coating.</s><s>The wells were washed three times with PBS and blocked with 5% HSA-PBS overnight at 4°C.</s><s>Blocked wells were washed and incubated with human TB24PB037 antibody, human control antibody (mGO53; <ref type="bibr" target="#b51">Wardemann et al, 2003)</ref>, or the positive control murine CS-35 antibody in 0.5% HSA-PBS overnight at 4°C.</s><s>The wells were washed and incubated with HRP-conjugated secondary antibody (1:1,000 dilution; Abcam) in 0.5% HSA-PBS for 2 h at RT.</s><s>The wells were washed and incubated with HRP substrate (Bio-Rad) at RT for 20 min.</s><s>The reaction was stopped with 0.2 N sulfuric acid, and the absorbance was measured at 450 nm.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Infection assay</head><p><s>A549 epithelial cells were grown overnight at 2.5 × 10 5 cells/well in 96-well plates.</s><s>Prior infection, THP-1 monocytic cells (1 × 10 6 cells/well) were differentiated into macrophages as described above.</s><s>H37Rv bacteria were grown to OD 0.4-0.8,</s><s>washed with PBS, and passaged five times through a tuberculin syringe to obtain single-cell suspensions.</s><s>Recombinant monoclonal antibodies at 10 lg/ml or diluted purified serum IgG/IgA were incubated with 1 × 10 8 bacteria for 1 h at 37°C.</s><s>The cells were washed with FCSfree medium and infected with H37Rv alone or with the antibody-H37Rv mix at an MOI of 1 for 1 h at 37°C.</s><s>Each condition was tested in triplicate.</s><s>Cells infected with MTB alone and infected with MTB preincubated with the monoclonal isotype control antibody (mGO53; <ref type="bibr" target="#b51">Wardemann et al, 2003)</ref> were used as internal controls.</s><s>Infected cells were vigorously washed four times with PBS and lysed with 0.5% Triton X-100.</s><s>Serial dilutions of cell lysates were plated, and the bacterial counts (CFUs) were enumerated at day 21.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Determination of FcRn expression by Western blot</head><p><s>A549 and THP1 cells were lysed for 5 min on ice with lysis buffer containing 25 mM Tris-HCl pH 7.4, 150 mM NaCl, 1% NP-40, 1 mM EDTA, and 5% glycerol (Pierce).</s><s>Cell debris was removed by centrifugation, and the cell supernatant was analyzed for FcRn and b-actin protein expression by Western blotting using the following antibodies: anti-human FcRn (1:20 dilution; Novus; NBP1-89128), anti-mouse b-actin (1:1,000; Cell Signaling Technology; 13E5), goat anti-mouse IgG HRP conjugate (1:5,000 dilution; Jackson Immuno-Research), and goat anti-rabbit HRP conjugate (1:5,000 dilution; Jackson ImmunoResearch).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Immunohistochemistry and immunofluorescence staining</head><p><s>Lung sections from MTB patients were fixed with 4% paraformaldehyde (PFA) for 1 h and 1% PFA overnight and then embedded in paraffin.</s><s>Immunostainings were performed after heat-mediated antigen retrieval, using DyLight TM 594 affinity-purified goat anti-human IgA (10 lg/ml; Jackson ImmunoResearch) and DyLight TM 649 IgG (10 lg/ml; Jackson ImmunoResearch).</s><s>Intracellular stainings with polyclonal rabbit anti-human Ki-67/MKI67 antibodies (1:100; Novus) followed by AlexaFluor488-conjugated anti-IgG secondary antibodies (1:100; Jackson ImmunoResearch) were performed after permeabilization with 0.5% Triton X-100.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistics</head><p><s>Statistical significance was determined as described in Appendix Table <ref type="table">S5</ref>.</s><s>D'Agostino-Pearson omnibus test was used to determine the normal distribution.</s><s>Unpaired t-test or Wilcoxon-Mann-Whitney test was used as indicated.</s><s>Statistical analyses were performed with GraphPad Prism software.</s><s>A value less than P &lt; 0.05 was considered statistically significant (*P &lt; 0.05, **P &lt; 0.01, ***P &lt; 0.001, ****P &lt; 0.0001).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study approval</head><p><s>All investigations have been conducted according to the Declaration of Helsinki principles.</s><s>Ethical approval was obtained from Charite Úniversity Institutional Review Board (No.</s><s>EA4/099/11).</s><s>Written informed consent was received from all participants prior to inclusion in the study.</s><s>Formalin-fixed, paraffin-embedded lung tissues from three patients with pulmonary MDR-TB were obtained from van Egmond M, van Vuuren AJ, Morton HC, van Spriel AB, Shen L, Hofhuis FM, Saito T, Mayadas TN, Verbeek JS, van de Winkel JG (1999) Human</s></p><p><s>The paper explained Problem Tuberculosis (TB) caused by Mycobacterium tuberculosis (MTB) is a life-threatening infectious disease and a major cause of death worldwide.</s><s>A vaccine is not available, and antibiotic resistance is becoming an increasing problem.</s><s>Antibodies against MTB may protect from infection and could be of therapeutic use, but human antibodies against MTB have not been described so far.</s><s>Here, we set out to identify and characterize human anti-MTB antibodies.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p><s>Our data show that antibodies against MTB are made in response to acute MTB infection, but also in healthy MTB-exposed individuals.</s><s>Many of the antibodies were IgA, the dominant antibody isotype produced at mucosal sites, suggesting that they developed during immune responses in the lung.</s><s>IgA anti-MTB antibodies bound to the surface of MTB and could thereby inhibit the infection of human lung cells.</s><s>Surprisingly, IgG antibodies, which are prominent during inflammatory conditions including MTB infection, had the opposite effect and promoted the infection.</s><s>These isotype-dependent differences in host cell infection were also observed with IgA and IgG serum antibodies.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Impact</head><p><s>Together, the data provide molecular insights into the human antibody response to MTB and suggest that antibody isotype differences may play a major role in modulating the course of the infection and the development and progression of disease in humans.</s><s>The targeted induction of IgA antibodies through vaccination may help to protect from MTB infection or promote immunity upon primary exposure.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>▸Figure 1 .</head><label>1</label><figDesc><div><p><s>Figure 1.</s><s>Anti-MTB serum antibody response in the peripheral blood of TB patients.</s><s>A Serum IgG ELISA reactivity with MTB (H37Rv) whole-cell lysate, purified cell membrane fraction, and secreted culture filtrate proteins (CFP) for TB patients and healthy donors (HD).</s><s>ELISA graphs (left; TB: black lines; n = 25; HD: red dotted lines; n = 2) and area under the curve (AUC) values for all tested samples (right; TB: n = 25; HD: n = 17) are shown.</s><s>Median is shown.</s><s>B AUC values for the IgA serum ELISA response against MTB whole-cell lysate, purified cell membrane fraction, and secreted culture filtrate proteins (CFP) of TB patients (n = 25) and healthy donors (HD; n = 9).</s><s>Median is shown.</s><s>C Flow cytometric gating strategy and frequency of circulating plasmablasts (CD19 + CD27 ++ CD38 + ) for one representative TB patient (TB24) and HD (left).</s><s>Frequency of circulating CD19 + CD27 ++ CD38 + plasmablasts of all CD19 + B cells in the peripheral blood of TB patients (n = 24) and HD (n = 8).</s><s>Dashed line indicates the threshold for detectable plasmablast populations (right).</s><s>Median and SEM are shown.</s><s>D Expression of CD19 and activation markers (CD86, CD84, and CD24) in the plasmablasts and memory B cells as measured by flow cytometry.</s><s>E Plasmablast response of patient TB7 (top) and IgG serum response against MTB cell lysates of patients TB7, TB19, and TB39 (bottom) and one HD at the indicated time points before and after the treatment onset.</s><s>F Dots indicate AUC values for the anti-MTB cell lysate IgG serum ELISA response (y-axis) versus the frequency of circulating plasmablasts (x-axis) for individual TB patients.</s><s>Spearman's correlation and corresponding P-value are shown.</s><s>Data information: All data are representative of two independent experiments.</s><s>(A and B) P-values were determined using Mann-Whitney test; **P &lt; 0.01; ****P &lt; 0.0001; ns, not significant.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head></head><label></label><figDesc><div><p><s>Figure1.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head></head><label></label><figDesc><div><p><s>200</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Figure 2 .</head><label>2</label><figDesc><div><p><s>Figure 2.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head></head><label></label><figDesc><div><p><s>E Dots indicate the frequency of HBHA-reactive memory B cells out of all CD27 + memory B cells in individual TB patients (n = 23) and HCW (n = 7).</s><s>Mean and SEM are indicated.</s><s>P-value was determined using Wilcoxon-Mann-Whitney test; ****P &lt; 0.0001.</s><s>F Dots indicate the frequency of resting memory B cells (CD19 + CD27 + CD10 À ) out of all B cells in the peripheral blood of individual TB patients compared with HCW.</s><s>G Anti-HBHA serum IgG ELISA reactivity for TB patients and HCW (black lines) compared with two representative HDs (red lines).</s><s>Dashed line indicates the threshold OD 405 nm for positive reactivity.</s><s>Asterisks indicate the serum responses of donors selected for single sorting of HBHA-reactive memory B cells.</s><s>Data are representative of two independent experiments.</s><s>H Absolute number of somatic hypermutations (SHM) in the IGHV (IGHA, IGHG, and IGHM), IGKV, or IGLV segments of sorted anti-HBHA memory cells from TB patients and HCW.</s><s>Geometric means with SEM are indicated in gray.</s><s>For comparison, red lines indicate the historic SHM means for randomly sorted CD27 + IgA + , CD27 + IgG + , or CD27 + IgM + cells from the peripheral blood of HDs (Tsuiji et al, 2006; Tiller et al, 2007; Berkowska et al, 2015).</s><s>I The number and size of clonally expanded B-cell clusters among HBHA-reactive memory B cells from two TB patients (TB35 and TB29) and HCW (HCW1 and HCW2).</s><s>Cells in clusters are indicated in gray, and single cells are indicated in white.</s><s>No B-cell clusters were shared between donors.</s><s>J IgA, IgG, and IgM isotype distribution of single-cell-sorted HBHA-reactive memory cells.</s><s>Mean and SEM are indicated.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>Figure 3 .Figure 4 .Figure 5 .</head><label>345</label><figDesc><div><p><s>Figure 3. Peripheral plasmablast antibodies from TB patients bind to mycobacterial surface antigens.</s><s>A total of 113 recombinant monoclonal plasmablast antibodies were generated and characterized for antimycobacterial reactivity.</s><s>A, B Representative ELISA graphs show the reactivity of antibodies from patient TB7 to (A) MTB whole-cell lysate or (B) MTB bacteria (left).</s><s>Dashed red line indicates the threshold OD 405 nm for positive reactivity.</s><s>Green line indicates the negative control antibody (mGO53; Wardemann et al, 2003).</s><s>AUC (area under curve) values indicate the reactivity to (A) MTB cell lysate or (B) whole MTB bacteria for antibodies from TB7, TB24, and TB33.</s><s>The total numbers of analyzed antibodies are indicated (right).</s><s>C Pie charts show the frequency of MTB-reactive (gray) vs. nonreactive (white) antibodies as measured by whole-cell lysate and MTB bacteria ELISA for each patient.</s><s>MTB-reactive antibodies were positive in both or one of the assays.</s><s>The total numbers of analyzed antibodies are indicated in the center of the charts.</s><s>D ELISA graph shows the reactivity to the MTB cell membrane fraction for MTB-reactive (n = 26) and nonreactive (n = 14) antibodies.</s><s>E Reactivity to whole BCG bacteria as determined by flow cytometry for three representative MTB cell lysate-reactive antibodies and one nonreactive antibody (isotype control, mGO53).</s><s>Data information: All data in (A, B, D, E) are representative of at least two independent experiments.</s></p></div></figDesc><graphic coords="6,213.46,323.84,71.28,76.96" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_7"><head></head><label></label><figDesc><div><p><s>Fig 6A).</s><s>However, epithelial cells were positive for the neonatal Fc receptor, which efficiently binds IgG and could thereby promote cell infection (Fig 6B; Spiekermann et al, 2002).</s><s>Despite the difference in CD89 and FccR expression, infection of macrophages with anti-LAM (TB24PB037) IgA-or IgGcoated MTB (Fig 6C) reproduced our findings in the epithelial cells (Fig 5).</s><s>Preincubation with IgA reduced the bacterial load, whereas IgG did not.</s><s>We conclude that the IgA-mediated blocking effect of MTB uptake (Figs 5 and</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_8"><head>Figure 6 .</head><label>6</label><figDesc><div><p><s>Figure 6.</s><s>Fc receptor expression on human lung epithelial cells.</s><s>A Human lung epithelial A549 cells and primary bronchial epithelial cells (hAECB) lack FccR (CD16, CD64, and CD32) and FcaR (CD89) cell surface expression as analyzed by flow cytometry.</s><s>Human THP1 cells serve as a positive control.</s><s>B The neonatal FcR (FcRn) is expressed in both A549 cells and human THP1 cells as determined by Western blotting.</s><s>Data are representative of at least two independent experiments.</s><s>C Absolute bacterial counts (CFUs) in human THP1 macrophages 1 h after infection with MTB preincubated with the LAM-reactive IgA1 (left) or IgG1 (right) antibody TB24PB037 or the respective isotype control antibody as indicated.</s><s>Mean and SEM are indicated.</s><s>Data information: Data are representative of three independent experiments.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_9"><head>Figure 7 .</head><label>7</label><figDesc><div><p><s>Figure 7. IgA and IgG isotype-associated differences in the effect of TB serum antibodies on MTB infection of human lung epithelial cells.</s><s>A Absolute bacterial counts (CFUs) in human lung epithelial A549 cells 1 h after infection with MTB preincubated with purified serum IgA (left) or IgG (right) antibodies from TB patients (TB) compared with HD as indicated.</s><s>Mean and SEM are indicated.</s><s>Data are representative of three independent experiments with three technical replicates each.</s><s>B Direct comparison of purified serum IgA and IgG antibodies on epithelial cell invasion as measured in (A).</s><s>P-value was determined using Wilcoxon-Mann-Whitney test; ****P &lt; 0.0001.</s><s>Data information: Data are representative of two independent experiments with three technical replicates each.</s><s>Dotted lines indicate the medium control.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="7,127.54,76.52,338.34,503.14" type="bitmap" /></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements</head><p><s>The authors thank Hugo Mouquet for IgA expression vectors, the BEI Resources Repository for reagents, and Simone Kocher for technical assistance.</s><s>N.Z.</s><s>was supported by the IMPRS-IDI Berlin.</s><s>S.H.E.K. acknowledges the support from the European Union's Seventh Framework Programme Project "ADITEC" (HEALTH-F4-2011-280873) and the European Union's Framework Programme for Research and Innovation "TBVAC 2020" (Grant No. 643381).</s></p><p><s>H.W. received funding by the DFG through TRR130 P10.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>the Republican Research and Practical Centre for Pulmonology and Tuberculosis (RRPCPT).</s><s>The use of human biopsies was based on informed patient consent and approved by the ethics commission of the RRPCPT.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Data availability</head><p><s>The data reported in this paper are tabulated in Appendix and are archived at GenBank (accession number KX947385-KX949063).</s></p><p><s>Expanded View for this article is available online.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Author contributions</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conflict of interest</head><p><s>The authors declare that they have no conflict of interest.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Alterations in the peripheral blood B cell subpopulations of multidrug-resistant tuberculosis patients</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Abreu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Carvalheiro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Rodrigues-Sousa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Domingos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Segorbe-Luis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Rodrigues-Santos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Souto-Carneiro</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Exp Med</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="423" to="429" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">B cells and antibodies in the defense against Mycobacterium tuberculosis infection</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Achkar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Casadevall</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunol Rev</title>
		<imprint>
			<biblScope unit="volume">264</biblScope>
			<biblScope unit="page" from="167" to="181" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Novel vaccination strategies against tuberculosis</title>
		<author>
			<persName><forename type="first">P</forename><surname>Andersen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Kaufmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cold Spring Harbor Perspect Med</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">18523</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">The human immunoglobulin A Fc receptor FcalphaRI: a multifaceted regulator of mucosal immunity</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Bakema</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Van Egmond</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mucosal Immunol</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="612" to="624" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">A novel human IgA monoclonal antibody protects against tuberculosis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Balu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Reljic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Lewis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Pleass</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Mcintosh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Van Kooten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Van Egmond</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Challacombe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Woof</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ivanyi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">186</biblScope>
			<biblScope unit="page" from="3113" to="3119" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Circulating human CD27-IgA+ memory B cells recognize bacteria with polyreactive Igs</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Berkowska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Schickel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Grosserichter-Wagener</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>De Ridder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">S</forename><surname>Ng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Van Dongen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Meffre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Van Zelm</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">195</biblScope>
			<biblScope unit="page" from="1417" to="1426" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Mycobacterium tuberculosis invades and replicates within type II alveolar cells</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Bermudez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Goodman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Infect Immun</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="1400" to="1406" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Infection of B cell-deficient mice with CDC 1551, a clinical isolate of Mycobacterium tuberculosis: delay in dissemination and development of lung pathology</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Bosio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Gardner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Elkins</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">164</biblScope>
			<biblScope unit="page" from="6417" to="6425" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">The role of Fc-FcgammaR interactions in IgG-mediated microbial neutralization</title>
		<author>
			<persName><forename type="first">S</forename><surname>Bournazos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Dilillo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">V</forename><surname>Ravetch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">212</biblScope>
			<biblScope unit="page" from="1361" to="1369" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Mucosal immunology of the upper airways: an overview</title>
		<author>
			<persName><forename type="first">P</forename><surname>Brandtzaeg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">L</forename><surname>Jahnsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">N</forename><surname>Farstad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Haraldsen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann N Y Acad Sci</title>
		<imprint>
			<biblScope unit="volume">830</biblScope>
			<biblScope unit="page" from="1" to="18" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Lipoarabinomannan-reactive human secretory immunoglobulin A responses induced by mucosal bacille Calmette-Guerin vaccination</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Cruz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Brennan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Gennaro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Schlesinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">A</forename><surname>Skeiky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">F</forename><surname>Hoft</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Infect Dis</title>
		<imprint>
			<biblScope unit="volume">187</biblScope>
			<biblScope unit="page" from="513" to="517" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">S</forename><surname>Buccheri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Reljic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Caccamo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ivanyi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Singh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Salerno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Dieli</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">IL-4 depletion enhances host resistance and passive IgA protection against tuberculosis infection in BALB/c mice</title>
	</analytic>
	<monogr>
		<title level="j">Eur J Immunol</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="729" to="737" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Demonstration of spread by Mycobacterium tuberculosis bacilli in A549 epithelial cell monolayers</title>
		<author>
			<persName><forename type="first">J</forename><surname>Castro-Garza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>King</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">E</forename><surname>Swords</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">D</forename><surname>Quinn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FEMS Microbiol Lett</title>
		<imprint>
			<biblScope unit="volume">212</biblScope>
			<biblScope unit="page" from="145" to="149" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Antibody bound to the surface antigen MPB83 of Mycobacterium bovis enhances survival against high dose and low dose challenge</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Chambers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Gavier-Widen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Hewinson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FEMS Immunol Med Microbiol</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="93" to="100" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Cell-mediated immune responses in tuberculosis</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Cooper</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Annu Rev Immunol</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="393" to="422" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Heterogeneity of antibody response to mycobacterial antigens in different clinical manifestations of pulmonary tuberculosis</title>
		<author>
			<persName><forename type="first">U</forename><surname>Demkow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Filewska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Michalowska-Mitczuk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Jagodzinski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Zielonka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Zwolska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Wasik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Rowinska-Zakrzewska</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Physiol Pharmacol</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="117" to="127" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">immunoglobulin A receptor (FcalphaRI, CD89) function in transgenic mice requires both FcR gamma chain and CR3 (CD11b/CD18)</title>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">93</biblScope>
			<biblScope unit="page" from="4387" to="4394" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Transmission of IgA and IgG monoclonal antibodies to mucosal fluids following intranasal or parenteral delivery</title>
		<author>
			<persName><forename type="first">G</forename><surname>Falero-Diaz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Challacombe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Rahman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mistry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Douce</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Dougan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Acosta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ivanyi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int Arch Allergy Immunol</title>
		<imprint>
			<biblScope unit="volume">122</biblScope>
			<biblScope unit="page" from="143" to="150" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Serum therapy for tuberculosis revisited: reappraisal of the role of antibody-mediated immunity against Mycobacterium tuberculosis</title>
		<author>
			<persName><forename type="first">A</forename><surname>Glatman-Freedman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Casadevall</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Microbiol Rev</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="514" to="532" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Macrophages in tuberculosis: friend or foe</title>
		<author>
			<persName><forename type="first">E</forename><surname>Guirado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Schlesinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Kaplan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Semin Immunopathol</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="563" to="583" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">A mycobacterial lipoarabinomannan specific monoclonal antibody and its F(ab&apos;) fragment prolong survival of mice infected with Mycobacterium tuberculosis</title>
		<author>
			<persName><forename type="first">B</forename><surname>Hamasur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Haile</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Pawlowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Schroder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Kallenius</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Svenson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Exp Immunol</title>
		<imprint>
			<biblScope unit="volume">138</biblScope>
			<biblScope unit="page" from="30" to="38" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">B</forename><surname>Kang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Azad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Torrelles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Kaufman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Beharka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Tibesar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Desjardin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Schlesinger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">202</biblScope>
			<biblScope unit="page" from="987" to="999" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guerin (BCG) in infected mice</title>
		<author>
			<persName><forename type="first">H</forename><surname>Kohama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Umemura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Okamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Yahagi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Goga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Harakuni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Matsuzaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Arakawa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Vaccine</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="924" to="932" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Chiu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wrammert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mccausland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">F</forename><surname>Andrews</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">Y</forename><surname>Zheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Qu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Edupuganti</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">109</biblScope>
			<biblScope unit="page" from="9047" to="9052" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Heparin-binding hemagglutinin, from an extrapulmonary dissemination factor to a powerful diagnostic and protective antigen against tuberculosis</title>
		<author>
			<persName><forename type="first">C</forename><surname>Locht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Hougardy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Rouanet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Place</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Mascart</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Tuberculosis</title>
		<imprint>
			<biblScope unit="volume">86</biblScope>
			<biblScope unit="page" from="303" to="309" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Induction of a protective response with an IgA monoclonal antibody against Mycobacterium tuberculosis 16 kDa protein in a model of progressive pulmonary infection</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Lopez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Yero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Falero-Diaz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Olivares</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Sarmiento</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sifontes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Solis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Barrios</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Aguilar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hernandez-Pando</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Med Microbiol</title>
		<imprint>
			<biblScope unit="volume">299</biblScope>
			<biblScope unit="page" from="447" to="452" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Efficient generation of human IgA monoclonal antibodies</title>
		<author>
			<persName><forename type="first">V</forename><surname>Lorin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Mouquet</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol Methods</title>
		<imprint>
			<biblScope unit="volume">422</biblScope>
			<biblScope unit="page" from="102" to="110" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">B cells moderate inflammatory progression and enhance bacterial containment upon pulmonary challenge with Mycobacterium tuberculosis</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Maglione</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Chan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">178</biblScope>
			<biblScope unit="page" from="7222" to="7234" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Fc gamma receptors regulate immune activation and susceptibility during Mycobacterium tuberculosis infection</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Maglione</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Casadevall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Chan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">180</biblScope>
			<biblScope unit="page" from="3329" to="3338" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Differential T and B cell responses against Mycobacterium tuberculosis heparin-binding hemagglutinin adhesin in infected healthy individuals and patients with tuberculosis</title>
		<author>
			<persName><forename type="first">C</forename><surname>Masungi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Temmerman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Van Vooren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Drowart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Pethe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">D</forename><surname>Menozzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Locht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Mascart</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Infect Dis</title>
		<imprint>
			<biblScope unit="volume">185</biblScope>
			<biblScope unit="page" from="513" to="520" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Identification of a heparin-binding hemagglutinin present in mycobacteria</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">D</forename><surname>Menozzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Rouse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Alavi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Laude-Sharp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Muller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bischoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Brennan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Locht</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">184</biblScope>
			<biblScope unit="page" from="993" to="1001" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Mycobacterium tuberculosis heparin-binding haemagglutinin adhesin (HBHA) triggers receptor-mediated transcytosis without altering the integrity of tight junctions</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">D</forename><surname>Menozzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">M</forename><surname>Reddy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Cayet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Raze</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Debrie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Dehouck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Cecchelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Locht</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Microbes Infect</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="1" to="9" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination</title>
		<author>
			<persName><forename type="first">K</forename><surname>Pethe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Alonso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Biet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Delogu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Brennan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Locht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">D</forename><surname>Menozzi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">412</biblScope>
			<biblScope unit="page" from="190" to="194" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Assessing humoral immune response of 4 recombinant antigens for serodiagnosis of tuberculosis</title>
		<author>
			<persName><forename type="first">P</forename><surname>Pukazhvanthen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Anbarasu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Basirudeen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Raja</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Singh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Tuberculosis</title>
		<imprint>
			<biblScope unit="volume">94</biblScope>
			<biblScope unit="page" from="622" to="633" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Divergent roles for Fc receptors and complement in vivo</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">V</forename><surname>Ravetch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Clynes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Rev Immunol</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="421" to="432" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Immunoglobulin transport across polarized epithelial cells</title>
		<author>
			<persName><forename type="first">R</forename><surname>Rojas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Apodaca</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Rev Mol Cell Biol</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="944" to="955" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Therapeutic efficacy of high-dose intravenous immunoglobulin in Mycobacterium tuberculosis infection in mice</title>
		<author>
			<persName><forename type="first">E</forename><surname>Roy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Stavropoulos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Brennan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Coade</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Grigorieva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Walker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Dagg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Tascon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Lowrie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Colston</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Infect Immun</title>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<biblScope unit="page" from="6101" to="6109" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Transcriptional profile of Mycobacterium tuberculosis replicating in type II alveolar epithelial cells</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Ryndak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">K</forename><surname>Singh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Peng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Laal</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">e0123745</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Type II alveolar cells play roles in macrophage-mediated host innate resistance to pulmonary mycobacterial infections by producing proinflammatory cytokines</title>
		<author>
			<persName><forename type="first">K</forename><surname>Sato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Tomioka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Shimizu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Gonda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Ota</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sano</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Infect Dis</title>
		<imprint>
			<biblScope unit="volume">185</biblScope>
			<biblScope unit="page" from="1139" to="1147" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Binding of the terminal mannosyl units of lipoarabinomannan from a virulent strain of Mycobacterium tuberculosis to human macrophages</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Schlesinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Hull</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Kaufman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">152</biblScope>
			<biblScope unit="page" from="4070" to="4079" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Small</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Hopewell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Singh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Paz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Parsonnet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Ruston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">F</forename><surname>Schecter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Daley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">K</forename><surname>Schoolnik</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">330</biblScope>
			<biblScope unit="page" from="1703" to="1709" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Mouse model recapitulating human Fcgamma receptor structural and functional diversity</title>
		<author>
			<persName><forename type="first">P</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Dilillo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bournazos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">V</forename><surname>Ravetch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">109</biblScope>
			<biblScope unit="page" from="6181" to="6186" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Receptor-mediated immunoglobulin G transport across mucosal barriers in adult life: functional expression of FcRn in the mammalian lung</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Spiekermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">W</forename><surname>Finn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Ward</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Dumont</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Dickinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Blumberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">I</forename><surname>Lencer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">196</biblScope>
			<biblScope unit="page" from="303" to="310" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<monogr>
		<title level="m" type="main">Conditionally reprogrammed cells represent a stem-like state of adult epithelial cells</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">A</forename><surname>Suprynowicz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Upadhyay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Krawczyk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Kramer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Hebert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Yuan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Cheluvaraju</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">W</forename><surname>Clapp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Boucher</surname><genName>Jr</genName></persName>
		</author>
		<imprint>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">109</biblScope>
			<date>20035 -20040</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival</title>
		<author>
			<persName><forename type="first">R</forename><surname>Teitelbaum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Glatman-Freedman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Robbins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Unanue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Casadevall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">R</forename><surname>Bloom</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="page" from="15688" to="15693" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Autoreactivity in human IgG+ memory B cells</title>
		<author>
			<persName><forename type="first">T</forename><surname>Tiller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tsuiji</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Yurasov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Velinzon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Nussenzweig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wardemann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunity</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="205" to="213" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning</title>
		<author>
			<persName><forename type="first">T</forename><surname>Tiller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Meffre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Yurasov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tsuiji</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Nussenzweig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wardemann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol Methods</title>
		<imprint>
			<biblScope unit="volume">329</biblScope>
			<biblScope unit="page" from="112" to="124" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Identification of Mycobacterium tuberculosis clinical isolates with altered phagocytosis by human macrophages due to a truncated lipoarabinomannan</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Torrelles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Knaup</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kolareth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Slepushkina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Kaufman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Kang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Hill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Brennan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Chatterjee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Belisle</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">283</biblScope>
			<biblScope unit="page" from="31417" to="31428" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">A checkpoint for autoreactivity in human IgM+ memory B cell development</title>
		<author>
			<persName><forename type="first">M</forename><surname>Tsuiji</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Yurasov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Velinzon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Nussenzweig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wardemann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">203</biblScope>
			<biblScope unit="page" from="393" to="400" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Predominant autoantibody production by early human B cell precursors</title>
		<author>
			<persName><forename type="first">H</forename><surname>Wardemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Yurasov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Schaefer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Young</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Meffre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Nussenzweig</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">301</biblScope>
			<biblScope unit="page" from="1374" to="1377" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Passive protection with immunoglobulin A antibodies against tuberculous early infection of the lungs</title>
		<author>
			<persName><forename type="first">A</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Reljic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Naylor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">O</forename><surname>Clark</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Falero-Diaz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Singh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Challacombe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">D</forename><surname>Marsh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ivanyi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunology</title>
		<imprint>
			<biblScope unit="volume">111</biblScope>
			<biblScope unit="page" from="328" to="333" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Rapid cloning of high-affinity human monoclonal antibodies against influenza virus</title>
		<author>
			<persName><forename type="first">J</forename><surname>Wrammert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">A</forename><surname>Langley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kokko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Larsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">Y</forename><surname>Zheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Mays</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Garman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Helms</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">453</biblScope>
			<biblScope unit="page" from="667" to="671" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Syndecans promote mycobacterial internalization by lung epithelial cells</title>
		<author>
			<persName><forename type="first">N</forename><surname>Zimmermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Saiga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Houthuys</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Moura-Alves</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Koehler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bandermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Dorhoi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Kaufmann</surname></persName>
		</author>
		<idno type="DOI">10.1111/cmi.12627</idno>
		<idno>doi: 10.1111/ cmi.12627</idno>
	</analytic>
	<monogr>
		<title level="j">Cell Microbiol</title>
		<imprint>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Baroness Masham of I (2013) WHO&apos;s 2013 global report on tuberculosis: successes, threats, and opportunities</title>
		<author>
			<persName><forename type="first">A</forename><surname>Zumla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>George</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Sharma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Herbert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">382</biblScope>
			<biblScope unit="page" from="1765" to="1767" />
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
